nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.286	1	CpDpCtD
Lidocaine—EGFR—chronic obstructive pulmonary disease	0.199	0.644	CbGaD
Lidocaine—CYP1A2—chronic obstructive pulmonary disease	0.11	0.356	CbGaD
Lidocaine—SLC22A5—Tiotropium—chronic obstructive pulmonary disease	0.0415	0.144	CbGbCtD
Lidocaine—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.0354	0.123	CbGbCtD
Lidocaine—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.0354	0.123	CbGbCtD
Lidocaine—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.0268	0.0929	CbGbCtD
Lidocaine—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0158	0.0545	CbGbCtD
Lidocaine—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0132	0.0458	CbGbCtD
Lidocaine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0122	0.0422	CbGbCtD
Lidocaine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0122	0.0422	CbGbCtD
Lidocaine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0115	0.0398	CbGbCtD
Lidocaine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0111	0.0386	CbGbCtD
Lidocaine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0111	0.0386	CbGbCtD
Lidocaine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.00993	0.0344	CbGbCtD
Lidocaine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.00935	0.0324	CbGbCtD
Lidocaine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.00923	0.032	CbGbCtD
Lidocaine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00631	0.0219	CbGbCtD
Lidocaine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00602	0.0209	CbGbCtD
Lidocaine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00537	0.0186	CbGbCtD
Lidocaine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00526	0.0182	CbGbCtD
Lidocaine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00496	0.0172	CbGbCtD
Lidocaine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00315	0.0109	CbGbCtD
Lidocaine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00297	0.0103	CbGbCtD
Lidocaine—Levobupivacaine—CYP1A2—chronic obstructive pulmonary disease	0.000527	0.294	CrCbGaD
Lidocaine—Bupivacaine—CYP1A2—chronic obstructive pulmonary disease	0.000421	0.235	CrCbGaD
Lidocaine—Ropivacaine—CYP1A2—chronic obstructive pulmonary disease	0.00034	0.19	CrCbGaD
Lidocaine—Tocainide—CYP1A2—chronic obstructive pulmonary disease	0.000319	0.178	CrCbGaD
Lidocaine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.00284	CcSEcCtD
Lidocaine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000212	0.00284	CcSEcCtD
Lidocaine—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.000211	0.00282	CcSEcCtD
Lidocaine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000208	0.00278	CcSEcCtD
Lidocaine—Neuropathy peripheral—Salbutamol—chronic obstructive pulmonary disease	0.000208	0.00278	CcSEcCtD
Lidocaine—Stomatitis—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.00277	CcSEcCtD
Lidocaine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000205	0.00274	CcSEcCtD
Lidocaine—Neuropathy—Prednisolone—chronic obstructive pulmonary disease	0.000204	0.00273	CcSEcCtD
Lidocaine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000203	0.00271	CcSEcCtD
Lidocaine—Rhinitis—Arformoterol—chronic obstructive pulmonary disease	0.000202	0.00271	CcSEcCtD
Lidocaine—Rhinitis—Formoterol—chronic obstructive pulmonary disease	0.000202	0.00271	CcSEcCtD
Lidocaine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.0002	0.00268	CcSEcCtD
Lidocaine—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000199	0.00266	CcSEcCtD
Lidocaine—Rhinitis—Montelukast—chronic obstructive pulmonary disease	0.000198	0.00265	CcSEcCtD
Lidocaine—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.000197	0.00263	CcSEcCtD
Lidocaine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000196	0.00262	CcSEcCtD
Lidocaine—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.000195	0.0026	CcSEcCtD
Lidocaine—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.000195	0.0026	CcSEcCtD
Lidocaine—Petechiae—Prednisone—chronic obstructive pulmonary disease	0.000192	0.00257	CcSEcCtD
Lidocaine—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.00256	CcSEcCtD
Lidocaine—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000191	0.00256	CcSEcCtD
Lidocaine—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.00256	CcSEcCtD
Lidocaine—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.00255	CcSEcCtD
Lidocaine—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.00254	CcSEcCtD
Lidocaine—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000188	0.00252	CcSEcCtD
Lidocaine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000188	0.00251	CcSEcCtD
Lidocaine—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.00251	CcSEcCtD
Lidocaine—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000187	0.00251	CcSEcCtD
Lidocaine—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.0025	CcSEcCtD
Lidocaine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000187	0.0025	CcSEcCtD
Lidocaine—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000185	0.00248	CcSEcCtD
Lidocaine—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000185	0.00248	CcSEcCtD
Lidocaine—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000185	0.00247	CcSEcCtD
Lidocaine—Tocainide—ALB—chronic obstructive pulmonary disease	0.000184	0.103	CrCbGaD
Lidocaine—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000183	0.00245	CcSEcCtD
Lidocaine—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000182	0.00244	CcSEcCtD
Lidocaine—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000182	0.00244	CcSEcCtD
Lidocaine—Contusion—Prednisone—chronic obstructive pulmonary disease	0.000181	0.00243	CcSEcCtD
Lidocaine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00018	0.0024	CcSEcCtD
Lidocaine—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000179	0.00239	CcSEcCtD
Lidocaine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000178	0.00238	CcSEcCtD
Lidocaine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000178	0.00238	CcSEcCtD
Lidocaine—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000178	0.00238	CcSEcCtD
Lidocaine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000178	0.00238	CcSEcCtD
Lidocaine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000177	0.00237	CcSEcCtD
Lidocaine—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.00237	CcSEcCtD
Lidocaine—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.00237	CcSEcCtD
Lidocaine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000176	0.00236	CcSEcCtD
Lidocaine—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000175	0.00234	CcSEcCtD
Lidocaine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000174	0.00233	CcSEcCtD
Lidocaine—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000173	0.00231	CcSEcCtD
Lidocaine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000172	0.00231	CcSEcCtD
Lidocaine—Tension—Formoterol—chronic obstructive pulmonary disease	0.000172	0.00231	CcSEcCtD
Lidocaine—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.0023	CcSEcCtD
Lidocaine—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000172	0.0023	CcSEcCtD
Lidocaine—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000172	0.0023	CcSEcCtD
Lidocaine—Chills—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.00229	CcSEcCtD
Lidocaine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.00228	CcSEcCtD
Lidocaine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000171	0.00228	CcSEcCtD
Lidocaine—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00017	0.00227	CcSEcCtD
Lidocaine—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00017	0.00227	CcSEcCtD
Lidocaine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000168	0.00225	CcSEcCtD
Lidocaine—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.00223	CcSEcCtD
Lidocaine—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.00221	CcSEcCtD
Lidocaine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000165	0.0022	CcSEcCtD
Lidocaine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000165	0.0022	CcSEcCtD
Lidocaine—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.00218	CcSEcCtD
Lidocaine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.00218	CcSEcCtD
Lidocaine—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00217	CcSEcCtD
Lidocaine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000161	0.00216	CcSEcCtD
Lidocaine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.00216	CcSEcCtD
Lidocaine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000161	0.00216	CcSEcCtD
Lidocaine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.00216	CcSEcCtD
Lidocaine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.00215	CcSEcCtD
Lidocaine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000161	0.00215	CcSEcCtD
Lidocaine—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.00215	CcSEcCtD
Lidocaine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00016	0.00213	CcSEcCtD
Lidocaine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000158	0.00212	CcSEcCtD
Lidocaine—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	0.000158	0.00211	CcSEcCtD
Lidocaine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000157	0.0021	CcSEcCtD
Lidocaine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.00208	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000153	0.00205	CcSEcCtD
Lidocaine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00204	CcSEcCtD
Lidocaine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000152	0.00203	CcSEcCtD
Lidocaine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000152	0.00203	CcSEcCtD
Lidocaine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00203	CcSEcCtD
Lidocaine—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00202	CcSEcCtD
Lidocaine—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.00201	CcSEcCtD
Lidocaine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00015	0.002	CcSEcCtD
Lidocaine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00015	0.002	CcSEcCtD
Lidocaine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00015	0.002	CcSEcCtD
Lidocaine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000149	0.00199	CcSEcCtD
Lidocaine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000149	0.00199	CcSEcCtD
Lidocaine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.00199	CcSEcCtD
Lidocaine—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.000149	0.00199	CcSEcCtD
Lidocaine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000146	0.00195	CcSEcCtD
Lidocaine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00195	CcSEcCtD
Lidocaine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.00192	CcSEcCtD
Lidocaine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.00192	CcSEcCtD
Lidocaine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000143	0.00192	CcSEcCtD
Lidocaine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000143	0.00192	CcSEcCtD
Lidocaine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.00192	CcSEcCtD
Lidocaine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.00189	CcSEcCtD
Lidocaine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000141	0.00189	CcSEcCtD
Lidocaine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.00188	CcSEcCtD
Lidocaine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000141	0.00188	CcSEcCtD
Lidocaine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000141	0.00188	CcSEcCtD
Lidocaine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00014	0.00188	CcSEcCtD
Lidocaine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00014	0.00188	CcSEcCtD
Lidocaine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000139	0.00186	CcSEcCtD
Lidocaine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000138	0.00184	CcSEcCtD
Lidocaine—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000136	0.00182	CcSEcCtD
Lidocaine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.00181	CcSEcCtD
Lidocaine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.00181	CcSEcCtD
Lidocaine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000134	0.00179	CcSEcCtD
Lidocaine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.00179	CcSEcCtD
Lidocaine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.00178	CcSEcCtD
Lidocaine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.00178	CcSEcCtD
Lidocaine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.00178	CcSEcCtD
Lidocaine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000131	0.00175	CcSEcCtD
Lidocaine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.00175	CcSEcCtD
Lidocaine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000128	0.00171	CcSEcCtD
Lidocaine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.00171	CcSEcCtD
Lidocaine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000127	0.00171	CcSEcCtD
Lidocaine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.00171	CcSEcCtD
Lidocaine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.00169	CcSEcCtD
Lidocaine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000126	0.00169	CcSEcCtD
Lidocaine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000125	0.00167	CcSEcCtD
Lidocaine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000125	0.00167	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000124	0.00166	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.00166	CcSEcCtD
Lidocaine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000123	0.00164	CcSEcCtD
Lidocaine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.00164	CcSEcCtD
Lidocaine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.00163	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000121	0.00162	CcSEcCtD
Lidocaine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.00161	CcSEcCtD
Lidocaine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.00161	CcSEcCtD
Lidocaine—Pain—Montelukast—chronic obstructive pulmonary disease	0.00012	0.00161	CcSEcCtD
Lidocaine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00012	0.0016	CcSEcCtD
Lidocaine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.0016	CcSEcCtD
Lidocaine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000119	0.00159	CcSEcCtD
Lidocaine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000119	0.00159	CcSEcCtD
Lidocaine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.00158	CcSEcCtD
Lidocaine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000118	0.00158	CcSEcCtD
Lidocaine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000118	0.00158	CcSEcCtD
Lidocaine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000118	0.00157	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.00156	CcSEcCtD
Lidocaine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.00155	CcSEcCtD
Lidocaine—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000115	0.00154	CcSEcCtD
Lidocaine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000114	0.00152	CcSEcCtD
Lidocaine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000114	0.00152	CcSEcCtD
Lidocaine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000113	0.00151	CcSEcCtD
Lidocaine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000112	0.0015	CcSEcCtD
Lidocaine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000112	0.0015	CcSEcCtD
Lidocaine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000112	0.0015	CcSEcCtD
Lidocaine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000112	0.0015	CcSEcCtD
Lidocaine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000112	0.00149	CcSEcCtD
Lidocaine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.00149	CcSEcCtD
Lidocaine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000111	0.00149	CcSEcCtD
Lidocaine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.00149	CcSEcCtD
Lidocaine—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.00147	CcSEcCtD
Lidocaine—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.00146	CcSEcCtD
Lidocaine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000109	0.00146	CcSEcCtD
Lidocaine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.00144	CcSEcCtD
Lidocaine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000106	0.00141	CcSEcCtD
Lidocaine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000106	0.00141	CcSEcCtD
Lidocaine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000106	0.00141	CcSEcCtD
Lidocaine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.00141	CcSEcCtD
Lidocaine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000103	0.00138	CcSEcCtD
Lidocaine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000103	0.00138	CcSEcCtD
Lidocaine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.00138	CcSEcCtD
Lidocaine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000101	0.00135	CcSEcCtD
Lidocaine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	9.98e-05	0.00133	CcSEcCtD
Lidocaine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	9.72e-05	0.0013	CcSEcCtD
Lidocaine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	9.67e-05	0.00129	CcSEcCtD
Lidocaine—Erythema—Prednisolone—chronic obstructive pulmonary disease	9.52e-05	0.00127	CcSEcCtD
Lidocaine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	9.48e-05	0.00127	CcSEcCtD
Lidocaine—Dizziness—Formoterol—chronic obstructive pulmonary disease	9.48e-05	0.00127	CcSEcCtD
Lidocaine—Dizziness—Montelukast—chronic obstructive pulmonary disease	9.29e-05	0.00124	CcSEcCtD
Lidocaine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	9.12e-05	0.00122	CcSEcCtD
Lidocaine—Vomiting—Formoterol—chronic obstructive pulmonary disease	9.12e-05	0.00122	CcSEcCtD
Lidocaine—Rash—Formoterol—chronic obstructive pulmonary disease	9.04e-05	0.00121	CcSEcCtD
Lidocaine—Rash—Arformoterol—chronic obstructive pulmonary disease	9.04e-05	0.00121	CcSEcCtD
Lidocaine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	9.03e-05	0.00121	CcSEcCtD
Lidocaine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	9.03e-05	0.00121	CcSEcCtD
Lidocaine—Headache—Arformoterol—chronic obstructive pulmonary disease	8.98e-05	0.0012	CcSEcCtD
Lidocaine—Headache—Formoterol—chronic obstructive pulmonary disease	8.98e-05	0.0012	CcSEcCtD
Lidocaine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	8.97e-05	0.0012	CcSEcCtD
Lidocaine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	8.95e-05	0.0012	CcSEcCtD
Lidocaine—Vomiting—Montelukast—chronic obstructive pulmonary disease	8.93e-05	0.00119	CcSEcCtD
Lidocaine—Rash—Montelukast—chronic obstructive pulmonary disease	8.86e-05	0.00118	CcSEcCtD
Lidocaine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	8.85e-05	0.00118	CcSEcCtD
Lidocaine—Headache—Montelukast—chronic obstructive pulmonary disease	8.8e-05	0.00118	CcSEcCtD
Lidocaine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	8.7e-05	0.00116	CcSEcCtD
Lidocaine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	8.67e-05	0.00116	CcSEcCtD
Lidocaine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	8.61e-05	0.00115	CcSEcCtD
Lidocaine—Rash—Salbutamol—chronic obstructive pulmonary disease	8.54e-05	0.00114	CcSEcCtD
Lidocaine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	8.53e-05	0.00114	CcSEcCtD
Lidocaine—Nausea—Formoterol—chronic obstructive pulmonary disease	8.52e-05	0.00114	CcSEcCtD
Lidocaine—Nausea—Arformoterol—chronic obstructive pulmonary disease	8.52e-05	0.00114	CcSEcCtD
Lidocaine—Headache—Salbutamol—chronic obstructive pulmonary disease	8.48e-05	0.00113	CcSEcCtD
Lidocaine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	8.36e-05	0.00112	CcSEcCtD
Lidocaine—Nausea—Montelukast—chronic obstructive pulmonary disease	8.34e-05	0.00112	CcSEcCtD
Lidocaine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	8.25e-05	0.0011	CcSEcCtD
Lidocaine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	8.22e-05	0.0011	CcSEcCtD
Lidocaine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	8.09e-05	0.00108	CcSEcCtD
Lidocaine—Nausea—Salbutamol—chronic obstructive pulmonary disease	8.04e-05	0.00108	CcSEcCtD
Lidocaine—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	7.98e-05	0.00107	CcSEcCtD
Lidocaine—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	7.94e-05	0.00106	CcSEcCtD
Lidocaine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	7.77e-05	0.00104	CcSEcCtD
Lidocaine—Oedema—Prednisolone—chronic obstructive pulmonary disease	7.77e-05	0.00104	CcSEcCtD
Lidocaine—Shock—Prednisolone—chronic obstructive pulmonary disease	7.64e-05	0.00102	CcSEcCtD
Lidocaine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	7.51e-05	0.001	CcSEcCtD
Lidocaine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	7.42e-05	0.000993	CcSEcCtD
Lidocaine—Flushing—Prednisone—chronic obstructive pulmonary disease	7.37e-05	0.000986	CcSEcCtD
Lidocaine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	7.21e-05	0.000964	CcSEcCtD
Lidocaine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	7.18e-05	0.00096	CcSEcCtD
Lidocaine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	6.97e-05	0.000933	CcSEcCtD
Lidocaine—Erythema—Prednisone—chronic obstructive pulmonary disease	6.92e-05	0.000925	CcSEcCtD
Lidocaine—Pain—Prednisolone—chronic obstructive pulmonary disease	6.64e-05	0.000888	CcSEcCtD
Lidocaine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	6.52e-05	0.000872	CcSEcCtD
Lidocaine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	6.4e-05	0.000856	CcSEcCtD
Lidocaine—Agitation—Prednisone—chronic obstructive pulmonary disease	6.35e-05	0.00085	CcSEcCtD
Lidocaine—Angioedema—Prednisone—chronic obstructive pulmonary disease	6.32e-05	0.000845	CcSEcCtD
Lidocaine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	6.17e-05	0.000825	CcSEcCtD
Lidocaine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	6.08e-05	0.000813	CcSEcCtD
Lidocaine—Convulsion—Prednisone—chronic obstructive pulmonary disease	5.99e-05	0.000801	CcSEcCtD
Lidocaine—Hypertension—Prednisone—chronic obstructive pulmonary disease	5.97e-05	0.000799	CcSEcCtD
Lidocaine—Anxiety—Prednisone—chronic obstructive pulmonary disease	5.87e-05	0.000785	CcSEcCtD
Lidocaine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	5.72e-05	0.000765	CcSEcCtD
Lidocaine—Oedema—Prednisone—chronic obstructive pulmonary disease	5.64e-05	0.000755	CcSEcCtD
Lidocaine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	5.64e-05	0.000755	CcSEcCtD
Lidocaine—Shock—Prednisone—chronic obstructive pulmonary disease	5.55e-05	0.000743	CcSEcCtD
Lidocaine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	5.53e-05	0.00074	CcSEcCtD
Lidocaine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	5.46e-05	0.00073	CcSEcCtD
Lidocaine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	5.14e-05	0.000687	CcSEcCtD
Lidocaine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	5.07e-05	0.000678	CcSEcCtD
Lidocaine—Rash—Prednisolone—chronic obstructive pulmonary disease	4.9e-05	0.000655	CcSEcCtD
Lidocaine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	4.89e-05	0.000654	CcSEcCtD
Lidocaine—Headache—Prednisolone—chronic obstructive pulmonary disease	4.87e-05	0.000651	CcSEcCtD
Lidocaine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	4.65e-05	0.000622	CcSEcCtD
Lidocaine—Nausea—Prednisolone—chronic obstructive pulmonary disease	4.61e-05	0.000617	CcSEcCtD
Lidocaine—Urticaria—Prednisone—chronic obstructive pulmonary disease	4.48e-05	0.0006	CcSEcCtD
Lidocaine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.16e-05	0.000556	CcSEcCtD
Lidocaine—Asthenia—Prednisone—chronic obstructive pulmonary disease	4.05e-05	0.000542	CcSEcCtD
Lidocaine—Dizziness—Prednisone—chronic obstructive pulmonary disease	3.73e-05	0.000499	CcSEcCtD
Lidocaine—Vomiting—Prednisone—chronic obstructive pulmonary disease	3.59e-05	0.00048	CcSEcCtD
Lidocaine—Rash—Prednisone—chronic obstructive pulmonary disease	3.56e-05	0.000476	CcSEcCtD
Lidocaine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.56e-05	0.000476	CcSEcCtD
Lidocaine—Headache—Prednisone—chronic obstructive pulmonary disease	3.54e-05	0.000473	CcSEcCtD
Lidocaine—Nausea—Prednisone—chronic obstructive pulmonary disease	3.35e-05	0.000448	CcSEcCtD
Lidocaine—CYP2C18—Metabolism—GCLC—chronic obstructive pulmonary disease	1.47e-05	0.000372	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.47e-05	0.000372	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.47e-05	0.000372	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—EGFR—chronic obstructive pulmonary disease	1.46e-05	0.000371	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	1.44e-05	0.000366	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—CD8A—chronic obstructive pulmonary disease	1.43e-05	0.000363	CbGpPWpGaD
Lidocaine—EGFR—Signaling by SCF-KIT—IL6—chronic obstructive pulmonary disease	1.43e-05	0.000363	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	1.43e-05	0.000363	CbGpPWpGaD
Lidocaine—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	1.42e-05	0.000361	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.41e-05	0.000358	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—LEP—chronic obstructive pulmonary disease	1.41e-05	0.000357	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.39e-05	0.000353	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	1.39e-05	0.000352	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.37e-05	0.000349	CbGpPWpGaD
Lidocaine—SLC22A5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.37e-05	0.000348	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling of activated FGFR—IL6—chronic obstructive pulmonary disease	1.37e-05	0.000347	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—TP53—chronic obstructive pulmonary disease	1.36e-05	0.000345	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	1.35e-05	0.000342	CbGpPWpGaD
Lidocaine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.35e-05	0.000341	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.34e-05	0.000341	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—CTGF—chronic obstructive pulmonary disease	1.34e-05	0.00034	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	1.34e-05	0.000339	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—ERBB3—chronic obstructive pulmonary disease	1.33e-05	0.000338	CbGpPWpGaD
Lidocaine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.33e-05	0.000336	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	1.31e-05	0.000331	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	1.29e-05	0.000327	CbGpPWpGaD
Lidocaine—EGFR—Downstream signal transduction—IL6—chronic obstructive pulmonary disease	1.29e-05	0.000326	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.29e-05	0.000326	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR—IL6—chronic obstructive pulmonary disease	1.28e-05	0.000325	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB2—IL6—chronic obstructive pulmonary disease	1.27e-05	0.000323	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.27e-05	0.000323	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—CRP—chronic obstructive pulmonary disease	1.27e-05	0.000322	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—IL6—chronic obstructive pulmonary disease	1.27e-05	0.000322	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.25e-05	0.000318	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.24e-05	0.000315	CbGpPWpGaD
Lidocaine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.24e-05	0.000313	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.23e-05	0.000313	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.23e-05	0.000312	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.23e-05	0.000311	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	1.22e-05	0.00031	CbGpPWpGaD
Lidocaine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.22e-05	0.000309	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—TLR4—chronic obstructive pulmonary disease	1.22e-05	0.000309	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.21e-05	0.000308	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—IL6—chronic obstructive pulmonary disease	1.19e-05	0.000303	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—chronic obstructive pulmonary disease	1.19e-05	0.000303	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—IL6—chronic obstructive pulmonary disease	1.19e-05	0.000303	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—MMP9—chronic obstructive pulmonary disease	1.18e-05	0.0003	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.18e-05	0.0003	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.18e-05	0.0003	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—IL6—chronic obstructive pulmonary disease	1.18e-05	0.0003	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—IL6—chronic obstructive pulmonary disease	1.17e-05	0.000297	CbGpPWpGaD
Lidocaine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.17e-05	0.000297	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—IL6—chronic obstructive pulmonary disease	1.17e-05	0.000296	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.16e-05	0.000295	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	1.16e-05	0.000294	CbGpPWpGaD
Lidocaine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.16e-05	0.000293	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.15e-05	0.000293	CbGpPWpGaD
Lidocaine—EGFR—Immune System—TLR2—chronic obstructive pulmonary disease	1.15e-05	0.000291	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.14e-05	0.000289	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	1.13e-05	0.000287	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—IL6—chronic obstructive pulmonary disease	1.12e-05	0.000285	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.09e-05	0.000276	CbGpPWpGaD
Lidocaine—EGFR—Immune System—KL—chronic obstructive pulmonary disease	1.08e-05	0.000273	CbGpPWpGaD
Lidocaine—EGFR—Disease—HDAC2—chronic obstructive pulmonary disease	1.07e-05	0.000272	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.06e-05	0.00027	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—VEGFA—chronic obstructive pulmonary disease	1.06e-05	0.00027	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	1.06e-05	0.000268	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.05e-05	0.000267	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.04e-05	0.000265	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.03e-05	0.000261	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.03e-05	0.00026	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.02e-05	0.000259	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.02e-05	0.000258	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.02e-05	0.000258	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.01e-05	0.000257	CbGpPWpGaD
Lidocaine—EGFR—Disease—KL—chronic obstructive pulmonary disease	9.96e-06	0.000253	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—TNF—chronic obstructive pulmonary disease	9.93e-06	0.000252	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.87e-06	0.00025	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	9.86e-06	0.00025	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	9.76e-06	0.000248	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	9.73e-06	0.000247	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.55e-06	0.000242	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.47e-06	0.00024	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.46e-06	0.00024	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	9.43e-06	0.000239	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	9.39e-06	0.000238	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	9.29e-06	0.000236	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	9.21e-06	0.000234	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.17e-06	0.000232	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.05e-06	0.00023	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.97e-06	0.000227	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	8.95e-06	0.000227	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	8.91e-06	0.000226	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	8.71e-06	0.000221	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CD8A—chronic obstructive pulmonary disease	8.69e-06	0.00022	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.64e-06	0.000219	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.56e-06	0.000217	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	8.52e-06	0.000216	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—MMP9—chronic obstructive pulmonary disease	8.45e-06	0.000214	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.38e-06	0.000213	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.21e-06	0.000208	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	8.19e-06	0.000208	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	8.16e-06	0.000207	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—IL6—chronic obstructive pulmonary disease	8.13e-06	0.000206	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.09e-06	0.000205	CbGpPWpGaD
Lidocaine—EGFR—Immune System—ERBB3—chronic obstructive pulmonary disease	8.08e-06	0.000205	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—IL6—chronic obstructive pulmonary disease	8.02e-06	0.000203	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	7.87e-06	0.0002	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.86e-06	0.000199	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	7.59e-06	0.000192	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.52e-06	0.000191	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	7.52e-06	0.000191	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.5e-06	0.00019	CbGpPWpGaD
Lidocaine—EGFR—Disease—ERBB3—chronic obstructive pulmonary disease	7.46e-06	0.000189	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CRP—chronic obstructive pulmonary disease	7.39e-06	0.000187	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	7.37e-06	0.000187	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—IL6—chronic obstructive pulmonary disease	7.36e-06	0.000187	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.32e-06	0.000186	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.3e-06	0.000185	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	7.22e-06	0.000183	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.14e-06	0.000181	CbGpPWpGaD
Lidocaine—EGFR—Immune System—TLR4—chronic obstructive pulmonary disease	7.09e-06	0.00018	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	7.06e-06	0.000179	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	7.02e-06	0.000178	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.97e-06	0.000177	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	6.97e-06	0.000177	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.84e-06	0.000174	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.82e-06	0.000173	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.75e-06	0.000171	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	6.59e-06	0.000167	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—TNF—chronic obstructive pulmonary disease	6.5e-06	0.000165	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	6.44e-06	0.000163	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.43e-06	0.000163	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.29e-06	0.00016	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.27e-06	0.000159	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.24e-06	0.000158	CbGpPWpGaD
Lidocaine—EGFR—Disease—NOS2—chronic obstructive pulmonary disease	6.22e-06	0.000158	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	6.19e-06	0.000157	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.19e-06	0.000157	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.18e-06	0.000157	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	6.11e-06	0.000155	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—ALB—chronic obstructive pulmonary disease	6.1e-06	0.000155	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	6.07e-06	0.000154	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.07e-06	0.000154	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.96e-06	0.000151	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.93e-06	0.00015	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—NOS3—chronic obstructive pulmonary disease	5.83e-06	0.000148	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.83e-06	0.000148	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.77e-06	0.000146	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.75e-06	0.000146	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.7e-06	0.000145	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.65e-06	0.000143	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	5.58e-06	0.000141	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.47e-06	0.000139	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.39e-06	0.000137	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	5.32e-06	0.000135	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.26e-06	0.000133	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—IL6—chronic obstructive pulmonary disease	5.25e-06	0.000133	CbGpPWpGaD
Lidocaine—EGFR—Disease—SERPINE1—chronic obstructive pulmonary disease	5.24e-06	0.000133	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.23e-06	0.000133	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.14e-06	0.00013	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.08e-06	0.000129	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.06e-06	0.000128	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.03e-06	0.000128	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.03e-06	0.000128	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	5.02e-06	0.000127	CbGpPWpGaD
Lidocaine—EGFR—Disease—NOS3—chronic obstructive pulmonary disease	5e-06	0.000127	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.99e-06	0.000127	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	4.97e-06	0.000126	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.95e-06	0.000125	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.88e-06	0.000124	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.86e-06	0.000123	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.72e-06	0.00012	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.68e-06	0.000119	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.65e-06	0.000118	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.64e-06	0.000118	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—IL6—chronic obstructive pulmonary disease	4.64e-06	0.000118	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IL1B—chronic obstructive pulmonary disease	4.61e-06	0.000117	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	4.58e-06	0.000116	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.55e-06	0.000115	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	4.54e-06	0.000115	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.48e-06	0.000114	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.41e-06	0.000112	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.31e-06	0.000109	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.3e-06	0.000109	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.29e-06	0.000109	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	4.25e-06	0.000108	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.23e-06	0.000107	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.22e-06	0.000107	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.18e-06	0.000106	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	4.05e-06	0.000103	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.96e-06	0.000101	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.94e-06	9.99e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	3.88e-06	9.84e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	3.88e-06	9.83e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.73e-06	9.47e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.73e-06	9.47e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	3.72e-06	9.42e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.68e-06	9.34e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.67e-06	9.31e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.55e-06	9.01e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.52e-06	8.92e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.5e-06	8.89e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.49e-06	8.85e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.47e-06	8.8e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.44e-06	8.72e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.43e-06	8.7e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.32e-06	8.42e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—TGFB1—chronic obstructive pulmonary disease	3.31e-06	8.39e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	3.28e-06	8.32e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.25e-06	8.25e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.23e-06	8.2e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.21e-06	8.13e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.11e-06	7.88e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.06e-06	7.77e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.04e-06	7.71e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	3e-06	7.6e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.99e-06	7.59e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.98e-06	7.56e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.96e-06	7.49e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.94e-06	7.45e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	2.93e-06	7.43e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.87e-06	7.27e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.81e-06	7.13e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	2.8e-06	7.11e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.76e-06	6.99e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.74e-06	6.95e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IL6—chronic obstructive pulmonary disease	2.7e-06	6.85e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.6e-06	6.58e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	2.54e-06	6.44e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.52e-06	6.4e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—IL6—chronic obstructive pulmonary disease	2.49e-06	6.32e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	2.43e-06	6.16e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.32e-06	5.88e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.3e-06	5.83e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.27e-06	5.75e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	2.21e-06	5.61e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.11e-06	5.36e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.11e-06	5.36e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	2.08e-06	5.28e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	2.07e-06	5.24e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2e-06	5.08e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.99e-06	5.05e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.98e-06	5.01e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.91e-06	4.84e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.76e-06	4.48e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.75e-06	4.43e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.69e-06	4.28e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.36e-06	3.45e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.3e-06	3.3e-05	CbGpPWpGaD
